![Charles Winter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Winter
Directeur Technique/Scientifique/R&D chez
JANUX THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Charles Winter is currently Chief Technical Officer at Janux Therapeutics, Inc. since 2021.
Former positions include Vice President-Chemistry, Manufacturing & Controls at AnaptysBio, Inc. (2020–2021), Vice President-Manufacturing & Controls at Synthorx, Inc. (2020), Head-Biologics at Denali Therapeutics, Inc. (2016–2018), Vice President-Manufacturing & Technology at Eden Biologics, Inc. (2015–2016), Director-Biologics Development at Gilead Sciences, Inc. (2011–2015), and Senior Group Leader & Principal Engineer at Genentech, Inc. (1994–2011).
Education includes undergraduate studies at the University of Wisconsin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC. 0,18 % | 02/01/2026 | 106 321 ( 0,18 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Charles Winter
| Sociétés | Poste | Début |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Anciens postes connus de Charles Winter
| Sociétés | Poste | Fin |
|---|---|---|
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 01/03/2021 |
| SYNTHORX, INC. | Corporate Officer/Principal | 01/08/2020 |
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 01/06/2018 |
| JHL BIOTECH, INC. | Directeur Technique/Scientifique/R&D | 01/08/2016 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2015 |
Formation de Charles Winter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that uses synthetic biology to discover and develop protein therapeutics | Health Technology |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
